We’re excited to announce a significant breakthrough in our protein production process!
Through meticulous lab work, we’ve discovered that a subtle adjustment – reducing the initial glucose concentration from 0.9% to 0.8% – has a dramatic impact on protein secretion. This minor change has resulted in a remarkable doubling of protein yield from our organism. The new batch being the second Th1 protein production for clinical trials.
This translates to:
- Significantly increased potency: Our protein powder now delivers a more potent dose of the desired protein per serving.
- Improved cost-effectiveness: By optimizing glucose utilization, we’ve reduced production costs without compromising on quality.
This achievement underscores our commitment to continuous improvement and innovation. We are dedicated to providing the highest quality products while minimizing our environmental impact.
Stay tuned for more exciting updates as we continue to refine our production processes and deliver even more effective and sustainable solutions.
